CADTH is seeking nominations for its Board of Directors, as well as expert and advisory committees. If you have significant expertise in the Canadian health care system, are interested in helping support health care decision-makers in making informed choices about health technologies, and are passionate about ensuring that the health care system in Canada is the best it can be, we encourage you to apply.
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers in Canada with objective evidence to help make informed decisions about the optimal use of drugs and medical devices in our health care system. CADTH receives funding from federal, provincial, and territorial governments in Canada, with the exception of Quebec. The business efforts of the CADTH Board and its committees are conducted in English.
Nominations must be submitted through our online form and received by Monday, April 24, 2023.
CADTH is seeking nominations for the positions that follow.
The CADTH Board of Directors has the overall responsibility for administering the affairs of the corporation and providing the strategic direction to guide CADTH's success as the go-to provider of evidence and advice in Canada on the use of drugs and other health technologies.
We are seeking
The CADTH Canadian Drug Expert Committee (CDEC) provides expert advice and makes drug reimbursement and optimal use recommendations through the CADTH Common Drug Review and Therapeutic Review processes.
We are seeking
The CADTH pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC) provides expert advice and makes oncology drug reimbursement recommendations through the pCODR process.
We are seeking
The CADTH Health Technology Expert Review Panel (HTERP) develops recommendations for CADTH projects related to diagnostic tests and medical, dental, and surgical devices and procedures.
We are seeking
The Patient and Community Advisory Committee (PCAC) comprises individuals with lived experience with the Canadian health care system and who are familiar with issues in health care in Canada. PCAC provides CADTH with advice on issues relevant to its mandate from the perspective of those who use the health care system in Canada.
We are seeking
As part of the CADTH Post-Market Drug Evaluation (PMDE) Program, the Advisory Committee is a multidisciplinary group that provides credible, strategic PMDE advice and expertise to CADTH on queries, strategic initiatives, and key priority areas. The Advisory Committee will also identify and support opportunities for stakeholder engagement in the program and promote the PMDE work of the program.
We are seeking
If you have the qualifications we seek, or know someone who does, we invite you to submit a nomination.
All nominees will receive a confirmation of receipt email. While CADTH thanks all nominees for their interest, only those under further consideration in the process will be contacted personally by email.
For more information, please consult the frequently asked questions (FAQs). If you have additional questions after reviewing the FAQs, please email them to us at requests@cadth.ca.
To request materials in an accessible format, please contact us at requests@cadth.ca.